[Ranitidine and cimetidine in the prevention of stress: ulcer hemorrhage a prospective comparative multicenter study]. 1984

H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller

In a multicentre single-blind study, ranitidine was compared to cimetidine as prophylactic treatment against stress-induced upper gastrointestinal bleeding in seriously ill patients in the intensive care unit (ICU). 380 patients entered the study. 192 patients were treated with ranitidine 50 mg q.i.d. as i.v. bolus followed by 150 mg orally twice daily. 188 patients received cimetidine 400 mg q.i.d. intravenously and 1,000 mg daily orally in divided doses. Five patients in the ranitidine group (2.6%) and 12 in the cimetidine group (6.4%) developed gastrointestinal bleeding definitely or possibly due to stress lesions. This difference was not significant. The incidence of stress erosions or ulcerations developing during the study was 11.8% for the ranitidine group and 18.3% for the cimetidine group (non-significant difference). Adverse events in the ranitidine group were nausea, tachycardia or vomiting in 4 patients. 5 cimetidine-treated patients developed cholestasis, and 5 additional central nervous system problems. The high degree of efficacy of both drugs compared very favourably with the high incidence of stress ulceration and hemorrhage in similar untreated populations.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010438 Peptic Ulcer Hemorrhage Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT. Hemorrhage, Peptic Ulcer,Peptic Ulcer Hemorrhages,Ulcer Hemorrhage, Peptic
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005860 Germany, West The former Federal Republic of Germany which was reunified with the former German Democratic Republic in 1990. Federal Republic of Germany,Germany, Federal Republic of
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
October 1985, Fortschritte der Medizin,
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
January 1986, Lijecnicki vjesnik,
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
October 1985, Lijecnicki vjesnik,
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
December 1983, Deutsche medizinische Wochenschrift (1946),
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
November 1984, The American journal of medicine,
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
March 1983, Deutsche medizinische Wochenschrift (1946),
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
July 1983, Deutsche medizinische Wochenschrift (1946),
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
September 1984, Lancet (London, England),
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
September 1988, Minerva chirurgica,
H O Barth, and P Berg, and G Brunner, and H G Dammann, and W Friedl, and F H Franken, and L Greiner, and J Groitl, and W Möckel, and P Müller
November 1980, British medical journal,
Copied contents to your clipboard!